MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business UpdateGlobeNewsWire • 08/06/25
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025GlobeNewsWire • 07/30/25
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/30/25
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23GlobeNewsWire • 06/09/25
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29GlobeNewsWire • 05/27/25
MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/08/25
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025GlobeNewsWire • 05/01/25
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment OptionsGlobeNewsWire • 04/07/25
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22GlobeNewsWire • 03/10/25
MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In QuestionSeeking Alpha • 02/27/25
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 02/26/25
Unveiling MannKind (MNKD) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 02/24/25
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025GlobeNewsWire • 02/19/25
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)GlobeNewsWire • 12/16/24